EMEA-001134-PIP01-11

Key facts

Active substance
Chimeric monoclonal anti-Shiga toxin antibodies cαStx1 and cαStx2
Therapeutic area
Infectious diseases
Decision number
P/308/2011
PIP number
EMEA-001134-PIP01-11
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Prevention of Shiga toxin-mediated complications
Route(s) of administration
Intravenous use
Contact for public enquiries
LFB Biotechnologies 
France 
roussariec@lfb.fr
+33 169828842 
+33 169827182
Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating